Goodwill of Jazz Pharmaceuticals plc from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Jazz Pharmaceuticals plc quarterly Goodwill in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Jazz Pharmaceuticals plc Goodwill for the quarter ending 30 Sep 2025 was $1,827,483,000, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Jazz Pharmaceuticals plc Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,827,483,000 +$22,837,000 +1.3% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,843,974,000 +$108,043,000 +6.2% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $1,760,045,000 +$20,550,000 +1.2% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $1,716,323,000 -$36,807,000 -2.1% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $1,804,646,000 +$99,326,000 +5.8% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,735,931,000 -$6,744,000 -0.39% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $1,739,495,000 +$16,051,000 +0.93% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $1,753,130,000 +$60,468,000 +3.6% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $1,705,320,000 +$112,685,000 +7.1% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $1,742,675,000 +$55,027,000 +3.3% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $1,723,444,000 -$59,000,000 -3.3% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $1,692,662,000 -$134,947,000 -7.4% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $1,592,635,000 -$256,912,000 -14% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,687,648,000 -$200,051,000 -11% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $1,782,444,000 +$844,046,000 +90% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $1,827,609,000 +$869,306,000 +91% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $1,849,547,000 +$912,448,000 +97% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $1,887,699,000 +$969,678,000 +106% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $938,398,000 +$29,172,000 +3.2% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $958,303,000 +$38,285,000 +4.2% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $937,099,000 +$30,374,000 +3.4% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $918,021,000 -$6,969,000 -0.75% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $909,226,000 -$10,746,000 -1.2% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $920,018,000 -$7,612,000 -0.82% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 $906,725,000 -$25,697,000 -2.8% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $924,990,000 -$11,503,000 -1.2% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $919,972,000 -$40,537,000 -4.2% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $927,630,000 -$19,907,000 -2.1% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 $932,422,000 -$9,006,000 -0.96% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $936,493,000 +$10,203,000 +1.1% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $960,509,000 +$61,219,000 +6.8% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $947,537,000 +$53,727,000 +6% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 $941,428,000 +$13,435,000 +1.4% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $926,290,000 +$264,445,000 +40% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $899,290,000 +$228,299,000 +34% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $893,810,000 +$236,671,000 +36% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $927,993,000 +$258,964,000 +39% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 $661,845,000 -$2,170,000 -0.33% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $670,991,000 +$16,521,000 +2.5% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $657,139,000 -$45,574,000 -6.5% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $669,029,000 -$55,359,000 -7.6% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $664,015,000 -$96,299,000 -13% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $654,470,000 -$109,293,000 -14% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $702,713,000 +$252,257,000 +56% 31 Dec 2014 10-K 23 Feb 2016 2015 FY
Q3 2014 $724,388,000 +$277,565,000 +62% 30 Sep 2014 10-Q 04 Nov 2014 2014 Q3
Q2 2014 $760,314,000 +$321,300,000 +73% 30 Jun 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 $763,763,000 +$327,408,000 +75% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $450,456,000 +$7,856,000 +1.8% 31 Dec 2013 10-K 24 Feb 2015 2014 FY
Q3 2013 $446,823,000 +$9,171,000 +2.1% 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 $439,014,000 -$7,222,000 -1.6% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 $436,355,000 +$196,618,000 +82% 31 Mar 2013 10-Q 07 May 2013 2013 Q1
Q4 2012 $442,600,000 +$404,387,000 +1058% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 $437,652,000 +$399,439,000 +1045% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $446,236,000 +$408,023,000 +1068% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $239,737,000 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 $38,213,000 $0 0% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 $38,213,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $38,213,000 30 Jun 2011 10-Q 03 Aug 2011 2011 Q2
Q4 2010 $38,213,000 31 Dec 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.